2019
DOI: 10.2147/dmso.s206981
|View full text |Cite
|
Sign up to set email alerts
|

<p>The association between omentin and diabetes: a systematic review and meta-analysis of observational studies</p>

Abstract: Aims: A number of studies have examined the association between the serum levels of omentin and diabetes, but the findings have been inconclusive. Herein, we systematically reviewed available observational studies to elucidate the overall relationship between omentin and diabetes, including type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), and impaired glucose tolerance (IGT) among adolescent and adult population. Methods: PubMed, Cochrane's Library, Science Direct, Scopus, Google Scholar, and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
17
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(17 citation statements)
references
References 62 publications
0
17
0
Order By: Relevance
“…In vitro and animal studies have shown that omentin enhances insulin action in human adipocytes and has beneficial effects on cardiovascular system [8,9]. Majority of the studies have shown that circulating levels of omentin are decreased in individuals with obesity and T2D [10][11][12][13] and positively associated with flow-mediated vasodilatation [14,15] suggesting a protective role of human omentin on cardiometabolic health. Even though omentin and adiponectin have been shown to have anti-inflammatory and cardioprotective effects, only a few studies have examined the physiological link between these adipokines in relation to cardiometabolic diseases [16,17].…”
Section: Introductionmentioning
confidence: 99%
“…In vitro and animal studies have shown that omentin enhances insulin action in human adipocytes and has beneficial effects on cardiovascular system [8,9]. Majority of the studies have shown that circulating levels of omentin are decreased in individuals with obesity and T2D [10][11][12][13] and positively associated with flow-mediated vasodilatation [14,15] suggesting a protective role of human omentin on cardiometabolic health. Even though omentin and adiponectin have been shown to have anti-inflammatory and cardioprotective effects, only a few studies have examined the physiological link between these adipokines in relation to cardiometabolic diseases [16,17].…”
Section: Introductionmentioning
confidence: 99%
“…Second, the GDM subgroup which was not included in the previous meta-analysis was included in this study and yielded significant results. Finally, unlike in the previous meta-analysis, this study further elaborated on the omentin-1 possible mechanism in the pathophysiology of diabetes [14].…”
Section: Discussionmentioning
confidence: 99%
“…Although a previous meta-analysis analyzed the relationship between concentrations ometin-1 and diabetes mellitus, that study focused only on T1DM and T2DM, and included only 28 articles. Therefore, it was necessary to conduct a more comprehensive systematic review and meta-analysis of this relationship [14]. Accordingly, the aim of this study was to use systematic review and meta-analysis methods to synthesize research results related to the association between omentin-1 concentrations and DM, and to measure the significance of this association.…”
Section: Introductionmentioning
confidence: 99%
“…In vitro and animal studies have shown that omentin enhances insulin action in human adipocytes and has beneficial effects on cardiovascular system [8, 9]. Majority of the studies have shown that circulating levels of omentin are decreased in individuals with obesity and T2D [1013] and positively associated with flow-mediated vasodilatation [14, 15] suggesting a protective role of human omentin on cardiometabolic health. Even though omentin and adiponectin have been shown to have anti-inflammatory and cardioprotective effects, only a few studies have examined the physiological link between these adipokines in relation to cardiometabolic diseases [16, 17].…”
Section: Introductionmentioning
confidence: 99%